FDA Inspection 1259994 — Transplant Services Center UT Southwestern Medical Center
The FDA completed an inspection of Transplant Services Center UT Southwestern Medical Center on Jan 24, 2025 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 24, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Dallas, TX (United States)